Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
Benjamin Vérillaud(Inserm), Pierre Busson(Université Paris-Sud), Michel Wassef(Université Paris Cité), Mélanie Gressette(Centre National de la Recherche Scientifique), Carine Paturel(Innate Pharma (France)), Yannis Morel(Innate Pharma (France)), Kwok Wai Lo(Chinese University of Hong Kong), Philippe Herman(Université Paris Cité), Sai Wah Tsao(Chinese University of Hong Kong), Anne-Sophie Jimenez-Pailhès(Centre National de la Recherche Scientifique)
Cited by 23
Related Papers
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
Epstein–Barr virus infection and nasopharyngeal carcinoma
|Philosophical Transactions of the Royal Society B Biological Sciences|2017|583
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
|The Journal of Pediatrics|1997|499
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
|Journal of Clinical Oncology|2018|473
Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features
|Pediatric and Developmental Pathology|2003|360